Silvercrest Asset Management Group Llc

Source: SEC Form 13F · as of Mar 2026

Silvercrest Asset Management Group Llc holds 57 biotech & pharma companies tracked by BioSniper, totaling $872.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

57

Total value held

$872.7M

CompanySharesValue
JNJJOHNSON & JOHNSON563,286$137.7M
ABTABBOTT LABORATORIES1,094,600$112.4M
CAHCardinal Health Inc.410,958$86.8M
GEHCGE HealthCare Technologies Inc.736,482$52.4M
ICUIICU Medical Inc.323,676$41.8M
MRKMerck & Co., Inc.257,228$30.9M
VCELVericel Corp959,207$30.9M
PBHPrestige Consumer Healthcare Inc.480,408$28.5M
AMGNAMGEN INC75,487$26.6M
AZNASTRAZENECA PLC122,435$24.1M
ABBVAbbVie Inc.110,500$24.0M
DGXQuest Diagnostics Incorporated114,758$22.5M
LNTHLantheus Holdings, Inc.292,806$22.2M
ELVElevance Health Inc.75,290$22.0M
CORCencora Inc.59,332$18.6M
MMSIMerit Medical Systems Inc.259,655$17.9M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)313,984$17.3M
QDELQuidelOrtho Corp892,407$14.7M
TWSTTwist Bioscience Corp244,025$11.6M
RGENREPLIGEN CORP85,107$10.0M
MDGLMADRIGAL PHARMACEUTICALS, INC.15,963$8.4M
PMPhilip Morris International Inc47,478$7.9M
MIRMMirum Pharmaceuticals, Inc.80,991$7.5M
CYRXCryoport, Inc.901,010$7.5M
VRTXVERTEX PHARMACEUTICALS INC / MA16,358$7.3M
ARWRARROWHEAD PHARMACEUTICALS, INC.108,413$6.8M
CSTLCastle Biosciences Inc.268,535$6.6M
CRNXCrinetics Pharmaceuticals, Inc.163,633$5.9M
LLYELI LILLY & Co6,368$5.9M
KNSAKiniksa Pharmaceuticals International, plc114,289$5.5M
PTGXProtagonist Therapeutics, Inc47,931$5.1M
NPCENeuropace Inc.360,065$4.7M
ZYMEZymeworks Inc.163,649$4.1M
BMYBRISTOL MYERS SQUIBB CO67,496$4.1M
RYTMRHYTHM PHARMACEUTICALS, INC.46,887$4.1M
GILDGILEAD SCIENCES, INC.25,960$3.6M
ALNYALNYLAM PHARMACEUTICALS, INC.10,429$3.5M
NUVBNuvation Bio Inc.724,383$3.1M
LENZLENZ Therapeutics, Inc.283,206$2.6M
BCYCBICYCLE THERAPEUTICS PLC428,684$2.0M
PFEPFIZER INC67,423$1.9M
NVSNovartis AG12,125$1.9M
ARGXARGENX SE2,487$1.8M
UNHUnitedHealth Group Incorporated Common Stock (DE)6,212$1.7M
MCKMcKesson Corporation1,371$1.2M
RVMDREVOLUTION MEDICINES, INC.7,905$769K
TECHBIO-TECHNE Corp11,005$575K
UTHRUNITED THERAPEUTICS Corp950$563K
IONSIONIS PHARMACEUTICALS INC7,053$530K
IDXXIDEXX LABORATORIES INC /DE872$490K
MDXGMiMedx Group Inc111,160$439K
CLPTClearPoint Neuro Inc.35,700$325K
ZTSZoetis Inc.2,739$324K
TVRDTvardi Therapeutics, Inc.101,034$321K
ALTAltimmune, Inc.103,500$319K
GMOptec International, Inc.3,940$294K
ZBHZimmer Biomet Holdings Inc.3,144$284K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.